Bio-Rad Laboratories BIO Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Bio-Rad Laboratories in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's total cost of revenue?
- Bio-Rad Laboratories (BIO) reported total cost of revenue of $282.7M in Q1 2026.
- How has Bio-Rad Laboratories's total cost of revenue changed year-over-year?
- Bio-Rad Laboratories's total cost of revenue increased by 1.2% year-over-year, from $279.4M to $282.7M.
- What is the long-term trend for Bio-Rad Laboratories's total cost of revenue?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories's total cost of revenue has grown at a -0.8% compound annual growth rate (CAGR), from $1.28B to $1.24B.
- What does total cost of revenue mean?
- The direct costs incurred to produce the products or services sold.
- How do you interpret total cost of revenue?
- An increase relative to revenue suggests declining production efficiency or rising input costs.
- How does total cost of revenue compare across companies?
- Varies by industry; manufacturing-heavy firms like Bio-Rad typically have higher cost of revenue ratios than software companies.